The pathogenicity of islet‐infiltrating lymphocytes in the non‐obese diabetic (NOD) mouse

The aim of the present study was to investigate the pathogenic properties of islet‐infiltrating lymphocytes related to the severity of the autoimmune destruction of islet β‐cells in the NOD mouse. We analysed the development of insulin‐dependent diabetes mellitus (IDDM) produced by adoptive transfer of islet lymphocytes from NOD into NOD.scid mice. Here we show that the transfer was most effective when both CD4+ and CD8+ T cells were present in the infiltrate, but CD4+ T cells alone were sufficient to cause the disease. Islet lymphocytes from both females and males transferred diabetes effectively, but the severity of IDDM was higher when female islet lymphocytes were used. Unexpectedly, the sensitivity of male islets to β‐cell damage was greater than that of female islets. Treatment of NOD females with a peptide of heat shock protein (hsp)60, p277, known to protect NOD mice from IDDM, reduced the pathogenicity of the islet lymphocytes. In contrast, administration of cyclophosphamide to males, a treatment that accelerates the disease, rendered the islet lymphocytes more pathogenic. More severe disease in the recipient NOD.scid mice was associated with more interferon‐gamma (IFN‐γ)‐secreting islet T cells of the NOD donor. The disease induced by islet lymphocytes was strongly inhibited by co‐transfer of spleen cells from prediabetic mice, emphasizing the regulatory role of peripheral lymphocytes. Thus, the cellular characteristics of the islet infiltrate and the pathogenicity of the cells are subject to complex regulation.

[1]  Irun R Cohen,et al.  Hsp60 Peptide Therapy of NOD Mouse Diabetes Induces a Th2 Cytokine Burst and Downregulates Autoimmunity to Various β-Cell Antigens , 1997, Diabetes.

[2]  E. Leiter,et al.  Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. , 1997, Journal of immunology.

[3]  Xiaojian Huang,et al.  Genetic Absence of γ-Interferon Delays but Does Not Prevent Diabetes in NOD Mice , 1996, Diabetes.

[4]  J. Peterson,et al.  Transfer of Diabetes in the NOD-scid Mouse by CD4 T-Cell Clones: Differential Requirement for CD8 T-Cells , 1996, Diabetes.

[5]  C. Fathman,et al.  Pathogenic and Protective Roles of CD45RBlow CD4+ Cells Correlate With Cytokine Profiles in the Spontaneously Autoimmune Diabetic Mouse , 1996, Diabetes.

[6]  H. Weiner,et al.  Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. , 1995, The American journal of pathology.

[7]  I. Cohen,et al.  Treatment of Autoimmune Diabetes and Insulitis in NOD Mice With Heat Shock Protein 60 Peptide p277 , 1995, Diabetes.

[8]  J. Bach Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation. , 1995, Journal of autoimmunity.

[9]  I. Cohen Treatment of autoimmune disease: to activate or to deactivate? , 1995, Chemical immunology.

[10]  A. Cooke,et al.  In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. , 1995, The Journal of clinical investigation.

[11]  W. Suarez-Pinzon,et al.  IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. , 1995, Journal of immunology.

[12]  A. Rabinovitch Immunoregulatory and Cytokine Imbalances in the Pathogenesis of IDDM: Therapeutic Intervention by Immunostimulation? , 1994, Diabetes.

[13]  K. Lafferty,et al.  Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. , 1993, Journal of autoimmunity.

[14]  E. Leiter,et al.  Adoptive Transfer of Diabetes Into Immunodeficient NOD-scid/scid Mice: Relative Contributions of CD4+ and CD8+ T-Cells From Diabetic Versus Prediabetic NOD.NON-Thy-1a Donors , 1993, Diabetes.

[15]  H. Fox,et al.  Androgen treatment prevents diabetes in nonobese diabetic mice , 1992, The Journal of experimental medicine.

[16]  H. Gaskins,et al.  The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Bach,et al.  Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. , 1991, Endocrinology.

[18]  I. Cohen,et al.  Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[19]  O. Pankewycz,et al.  Islet‐infiltrating T cell clones from non‐obese diabetic mice that promote or prevent accelerated onset diabetes , 1991, European journal of immunology.

[20]  P. Bedossa,et al.  Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. , 1991, Journal of autoimmunity.

[21]  A. Baxter,et al.  Comparison of High— and Low—Diabetes-Incidence NOD Mouse Strains , 1989, Diabetes.

[22]  A. Baxter,et al.  Comparison of high and low diabetes incidence non-obese diabetic mouse strains , 1989 .

[23]  C. Boitard,et al.  T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice , 1989, The Journal of experimental medicine.

[24]  Th. Mandel,et al.  Progression From Insulitis to β-Cell Destruction in NOD Mouse Requires L3T4+ T-Lymphocytes , 1988, Diabetes.

[25]  J. Bach,et al.  Anti‐suppressor effect of cyclophosphamide on the development of spontaneous diabetes in nod mice , 1988, European journal of immunology.

[26]  L. Wicker,et al.  Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. , 1988, Journal of immunology.

[27]  A. Rabinovitch,et al.  Destruction of Rat Islet Cell Monolayers by Cytokines: Synergistic Interactions of Interferon-γ, Tumor Necrosis Factor, Lymphotoxin, and Interleukin 1 , 1988, Diabetes.

[28]  C. Boitard,et al.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells , 1987, The Journal of experimental medicine.

[29]  D. Greiner,et al.  Depletion of RT6.1+ T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats , 1987, The Journal of experimental medicine.

[30]  P. Holt,et al.  The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. An overview. , 1986, Journal of immunological methods.

[31]  A. Monaco,et al.  An improved method for isolation of mouse pancreatic islets. , 1985, Transplantation.

[32]  B. Woda,et al.  Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat. , 1984, The Journal of clinical investigation.

[33]  B. Haynes,et al.  The BB Diabetic Rat: Profound T-Cell Lymphocytopenia , 1981, Diabetes.

[34]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[35]  W. Gepts Pathologic Anatomy of the Pancreas in Juvenile Diabetes Mellitus , 1965, Diabetes.